Metagenomi, Inc. Common Stock (MGX) Financials

$2.65

north_east
$0.16 (6.43%)
Day's range
$2.49
Day's range
$2.71

MGX Income statement / Annual

Last year (2024), Metagenomi, Inc. Common Stock's total revenue was $52.30 M, an increase of 16.84% from the previous year. In 2024, Metagenomi, Inc. Common Stock's net income was -$78.06 M. See Metagenomi, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $52.30 M $44.76 M $17.20 M $243.00 K
Cost of Revenue $0.00 $94.40 M $1.73 M $387.00 K
Gross Profit $52.30 M -$49.65 M $15.47 M -$144.00 K
Gross Profit Ratio 1 -1.11 0.9 -0.59
Research and Development Expenses $109.18 M $94.40 M $43.14 M $14.48 M
General & Administrative Expenses $32.02 M $28.85 M $18.70 M $9.71 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $32.02 M $28.85 M $18.70 M $9.71 M
Other Expenses $0.00 -$94.40 M -$1.73 M -$387.00 K
Operating Expenses $141.20 M $28.85 M $60.11 M $23.80 M
Cost And Expenses $141.20 M $123.25 M $61.84 M $24.19 M
Interest Income $14.72 M $15.47 M $3.42 M $43.00 K
Interest Expense $0.00 $0.00 $98.00 K $302.00 K
Depreciation & Amortization $5.41 M $4.21 M $1.73 M $387.00 K
EBITDA -$83.49 M -$74.29 M -$39.19 M -$20.75 M
EBITDA Ratio -1.6 -1.66 -2.28 -85.4
Operating Income Ratio -1.7 -1.75 -2.6 -98.55
Total Other Income/Expenses Net $5.33 M $18.26 M $3.62 M $2.51 M
Income Before Tax -$83.57 M -$60.23 M -$41.02 M -$21.44 M
Income Before Tax Ratio -1.6 -1.35 -2.39 -88.24
Income Tax Expense -$5.51 M $8.03 M $2.57 M $0.00
Net Income -$78.06 M -$68.26 M -$43.59 M -$21.44 M
Net Income Ratio -1.49 -1.53 -2.53 -88.24
EPS -2.09 -1.82 -1.16 -3.62
EPS Diluted -2.09 -1.82 -1.16 -3.62
Weighted Average Shares Out $37.42 M $37.47 M $37.47 M $5.93 M
Weighted Average Shares Out Diluted $37.42 M $37.47 M $37.47 M $5.93 M
Link